Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis
Copyright © Targeted News Service 2024
2024-04-23
ALEXANDRIA, Virginia, April 24 -- INTELLIA THERAPEUTICS, INC., Cambridge, Massachusetts has been assigned a patent (No. US 11965165 B2, initially filed Dec. 9, 2022) developed by five inventors Arti Mahendra Prakash Kanjolia, Malden, Massachusetts; Shobu Odate, Arlington, Massachusetts; Jessica Lynn Seitzer, Windham, New Hampshire; Reynald Michael Lescarbeau, Medford, Massachusetts; and Walter Strapps, Dedham, Massachusetts, for "Compositions and methods for TTR gene editing and treating ATTR a . . .